Clinical Trial Update: Dengvaxia US Pregnancy Registry

View source ↗

Summary

A US pregnancy registry for the dengue vaccine Dengvaxia is currently recruiting to collect data on pregnancy exposures and outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue

Drugs mentioned

• Dengvaxia (CYD-TDV)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Dengue Virus Infection | Status: RECRUITING